MyFinsight
Home
About
Contact
Back
Income Statement
BOSTON SCIENTIFIC CORP (BSX)
source: myfinsight.com
Download
Download image
Cardiovascular
$3,341M
Medsurg
$1,714M
Impact of foreign
currency fluctuations
$6M
(-25.00%↓ Y/Y)
Net sales of
reportable...
$5,055M
Net sales
$5,061M
(22.84%↑ Y/Y)
Gross profit
$3,424M
(20.14%↑ Y/Y)
Cost of products sold
$1,637M
(28.90%↑ Y/Y)
Other, net
$213M
Operating income (loss)
$819M
(57.50%↑ Y/Y)
Operating expenses
$2,605M
(11.80%↑ Y/Y)
Contingent consideration
net expense...
-$5M
(-350.00%↓ Y/Y)
Income (loss)before
income taxes
$941M
(124.05%↑ Y/Y)
Interest expense
$90M
(16.88%↑ Y/Y)
Amortization expense
$225M
(5.63%↑ Y/Y)
Intangible asset
impairment charges
$46M
(-83.33%↓ Y/Y)
Research and development
expenses
$526M
(37.34%↑ Y/Y)
Restructuring net charges
(credits)
$83M
(8200.00%↑ Y/Y)
Royalty expense
$14M
(55.56%↑ Y/Y)
Selling, general and
administrative expenses
$1,716M
(18.67%↑ Y/Y)
Net income (loss)
attributable to...
-$2M
(0.00%↑ Y/Y)
Net income (loss)
$795M
(146.89%↑ Y/Y)
Income tax expense
(benefit)
$146M
(48.98%↑ Y/Y)
Net income (loss)
attributable to boston...
$797M
(145.99%↑ Y/Y)
Back